Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients

by Wilma E. Mesker, Gerrit-Jan Liefers, Jan M. C. Junggeburt, Gabi W. van Pelt, Paola Alberici, Peter J. K. Kuppen, Noel F. Miranda, Karin A. M. van Leeuwen, Hans Morreau, Karoly Szuhai, Rob A. E. M. Tollenaar, Hans J. Tanke
Published 2009-01-01